FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1520525240> ?p ?o ?g. }

• W1520525240 abstract "<p>Classic kappa opioid receptor (KOPr) agonists have shown anti-addictive properties in rat models of addiction (Heidbreder et al. 1998; Schenk et al. 1999; Sun et al. 2010), and this has been shown to be partially through modulation of dopamine and serotonin in the synapse (Thompson et al. 2000; Zhang et al. 2004; Zakharova et al. 2008a). However, they have side effects such as depression and dysphoria and therefore have not been moved into the clinic. The novel KOPr agonist salvinorin A has a completely different structure compared to the classic agonists, and along with its novel analogues has opened up a new family of KOPr agonists which may possess anti-addictive properties and have the potential to have decreased side effects. Salvinorin A has also demonstrated anti-addictive properties (Morani et al. 2009). In this study the novel KOPr agonist salvinorin A and its analogues DS-1-240 and DS-3-216 were investigated, along with the classic agonists U50,488H and U69,593. Their effects on the dopamine transporter (DAT) were measured using isolated rat brain tissue and cell models. The effects of U50,488H and salvinorin A on the serotonin transporter (SERT) was also measured in rat striatum using rotating disk electrode voltammetry, which was established to measure serotonin uptake in our lab during this study. We found that all of the kappa opioid receptor agonists studied in isolated rat brain tissue caused dose dependent increases in uptake of dopamine by the dopamine transporter and a decrease in uptake of serotonin by the serotonin transporter. The effect on the serotonin transporter was observed after a 15 min incubation with the agonists. Salvinorin A had a faster effect on the dopamine transporter than the other compounds investigated, with increases measured at 1 min rather than 4 min. DAT kinetics showed increases in Vmax for all agonists investigated, and both U69,593 and DS-1-240 also showed increased Km values. This demonstrates an overall increase in function, with the possibility of increased cell surface expression. Further investigation using cell models also found an increase in uptake of the fluorescent monoamine transporter substrate ASP+ by YFP tagged human DAT (YFP-hDAT). This effect was seen with all the agonists studied after incubations of less than 5 min and was YFP-hDAT trafficking-independent. The increase in uptake seen may be due to increased active YFP-hDAT found on the cell membrane as ASP+ binding studies demonstrated an increase in binding. The acute increase in YFP-hDAT function was found to be ERK1/2 dependent for all compounds studied, and was also dependent on intact lipid rafts in the cell membrane. After a 30 min incubation, salvinorin A and U50,488H still caused increased uptake of ASP+ by YFP-hDAT, whereas DS-1-240 and DS-3-216 did not. Increases in cell surface expression of YFP-hDATwas seen at this time point with salvinorin A, U69,593, and DS-3-216. Further investigation into this found that the increase in cell surface expression of YFP-hDAT after salvinorin A treatment was ERK1/2 dependent, whereas the increase seen with U69,593 appeared to be ERK1/2 independent. Overall, this data demonstrates that KOPr rapidly regulates DAT function by a trafficking-independent, ERK1/2-, and lipid raft-dependent mechanism. The classic KOPr agonist U50,488H and salvinorin A also caused a decrease in serotonin uptake by SERT, confirming that the KOPr also regulates SERT. The data from this study provides more information on how these classic and novel KOPr agonists function to regulate DAT and SERT, which may help explain some of the anti-addictive properties displayed by these compounds.</p>" @default.
• W1520525240 created "2016-06-24" @default.
• W1520525240 creator A5089856157 @default.
• W1520525240 date "2021-11-10" @default.
• W1520525240 modified "2023-10-12" @default.
• W1520525240 title "Investigating the Effects of Novel Kappa Opioid Receptor Agonists on the Dopamine Transporter" @default.
• W1520525240 cites W142226571 @default.
• W1520525240 cites W1499533611 @default.
• W1520525240 cites W1515561322 @default.
• W1520525240 cites W1522958406 @default.
• W1520525240 cites W1523600088 @default.
• W1520525240 cites W1531318037 @default.
• W1520525240 cites W1538357606 @default.
• W1520525240 cites W1539090868 @default.
• W1520525240 cites W1598676150 @default.
• W1520525240 cites W1616315782 @default.
• W1520525240 cites W1645031292 @default.
• W1520525240 cites W1696743006 @default.
• W1520525240 cites W1795329520 @default.
• W1520525240 cites W1839259206 @default.
• W1520525240 cites W1852077611 @default.
• W1520525240 cites W1860158865 @default.
• W1520525240 cites W1866229087 @default.
• W1520525240 cites W1876475223 @default.
• W1520525240 cites W1891611023 @default.
• W1520525240 cites W1898469558 @default.
• W1520525240 cites W1906373710 @default.
• W1520525240 cites W1917554980 @default.
• W1520525240 cites W1920778929 @default.
• W1520525240 cites W1938622267 @default.
• W1520525240 cites W1951617736 @default.
• W1520525240 cites W1955225173 @default.
• W1520525240 cites W1964943018 @default.
• W1520525240 cites W1964979617 @default.
• W1520525240 cites W1965689912 @default.
• W1520525240 cites W1966058177 @default.
• W1520525240 cites W1966136869 @default.
• W1520525240 cites W1966233483 @default.
• W1520525240 cites W1966339135 @default.
• W1520525240 cites W1966583126 @default.
• W1520525240 cites W1966663884 @default.
• W1520525240 cites W1966809419 @default.
• W1520525240 cites W1967241882 @default.
• W1520525240 cites W1967859700 @default.
• W1520525240 cites W1968670700 @default.
• W1520525240 cites W1968683631 @default.
• W1520525240 cites W1969831870 @default.
• W1520525240 cites W1970407380 @default.
• W1520525240 cites W1970655997 @default.
• W1520525240 cites W1970870670 @default.
• W1520525240 cites W1971631414 @default.
• W1520525240 cites W1972911661 @default.
• W1520525240 cites W1972943445 @default.
• W1520525240 cites W1974504536 @default.
• W1520525240 cites W1974770964 @default.
• W1520525240 cites W1977471961 @default.
• W1520525240 cites W1977710785 @default.
• W1520525240 cites W1979031324 @default.
• W1520525240 cites W1981073133 @default.
• W1520525240 cites W1981291913 @default.
• W1520525240 cites W1981629237 @default.
• W1520525240 cites W1981891173 @default.
• W1520525240 cites W1981899418 @default.
• W1520525240 cites W1982112098 @default.
• W1520525240 cites W1982933223 @default.
• W1520525240 cites W1983399730 @default.
• W1520525240 cites W1984711181 @default.
• W1520525240 cites W1985627109 @default.
• W1520525240 cites W1985721952 @default.
• W1520525240 cites W1985814681 @default.
• W1520525240 cites W1985833159 @default.
• W1520525240 cites W1986194711 @default.
• W1520525240 cites W1987324543 @default.
• W1520525240 cites W1988775634 @default.
• W1520525240 cites W1988806515 @default.
• W1520525240 cites W1989416066 @default.
• W1520525240 cites W1989756310 @default.
• W1520525240 cites W1990267962 @default.
• W1520525240 cites W1990492557 @default.
• W1520525240 cites W1990745212 @default.
• W1520525240 cites W1991123914 @default.
• W1520525240 cites W1991571301 @default.
• W1520525240 cites W1991882455 @default.
• W1520525240 cites W1992746782 @default.
• W1520525240 cites W1992909065 @default.
• W1520525240 cites W1993357003 @default.
• W1520525240 cites W1993599005 @default.
• W1520525240 cites W1993969719 @default.
• W1520525240 cites W1994055253 @default.
• W1520525240 cites W1994234461 @default.
• W1520525240 cites W1994453605 @default.
• W1520525240 cites W1994661693 @default.
• W1520525240 cites W1994735827 @default.
• W1520525240 cites W1995219231 @default.
• W1520525240 cites W1995492072 @default.
• W1520525240 cites W1996987808 @default.
• W1520525240 cites W1998489561 @default.
• W1520525240 cites W1998852714 @default.
• W1520525240 cites W1998863061 @default.
• W1520525240 cites W1999737174 @default.

• next